Wockhardt Limited has reported a remarkable 54% surge in net profit for the second quarter of the financial year 2025, ending September 30, 2025. The company recorded a profit of ₹54 crore, compared to a loss of ₹36 crore during the same period last year. This significant improvement can be attributed to a rise in revenue from operations, which reached ₹380 crore, an increase from ₹370 crore in Q2 2024. The total income for the quarter stood at ₹410 crore, showcasing a robust performance driven by effective cost management and operational efficiency.

In addition to the impressive financial results, Wockhardt's Board of Directors has approved the appointment of Mr. Om Prakash Bhatt as an Additional Non-Executive Independent Director, effective from November 3, 2025. Mr. Bhatt brings extensive experience to the role, having served as the Chairman and CEO of the State Bank of India and holding independent director positions in various multinational companies. His appointment is seen as a strategic move to enhance the company’s governance and strategic direction, with a recommendation for a five-year term pending shareholder approval.

The company’s total expenses for the quarter were ₹356 crore, which reflects a decrease from the previous year, highlighting Wockhardt’s successful efforts in optimizing operational costs. The earnings per share (EPS) stood at ₹3.26, up from a negative EPS of ₹2.34 for the same quarter last year. With a robust financial performance and strengthened leadership, Wockhardt is poised for further growth as it navigates the competitive pharmaceutical landscape in India and beyond.